Viracta Therapeutics Asset Turnover 2010-2024 | VIRX

Viracta Therapeutics asset turnover from 2010 to 2024. Asset turnover can be defined as the amount of sales or revenues generated per dollar of assets. The asset turnover ratio is an indicator of the efficiency with which a company is deploying its assets.

Viracta Therapeutics Asset Turnover 2010-2024 | VIRX

Viracta Therapeutics asset turnover from 2010 to 2024. Asset turnover can be defined as the amount of sales or revenues generated per dollar of assets. The asset turnover ratio is an indicator of the efficiency with which a company is deploying its assets.
Related Stocks
Company NameMarket
Cap
Zoetis (ZTS)$73.4B
Chugai Pharmaceutical (CHGCY)$72.5B
Takeda Pharmaceutical (TAK)$42.2B
Merck (MKKGY)$18.5B
Sandoz Group AG (SDZNY)$17.9B
Astellas Pharma (ALPMY)$17.4B
United Therapeutics (UTHR)$16.1B
Neurocrine Biosciences (NBIX)$14B
Summit Therapeutics (SMMT)$13.5B
Shionogi (SGIOY)$11.9B
Madrigal Pharmaceuticals (MDGL)$6.8B
Orion OYJ (ORINY)$6.2B
Ionis Pharmaceuticals (IONS)$5.5B
Corcept Therapeutics (CORT)$5.2B
Crinetics Pharmaceuticals (CRNX)$4.8B
PTC Therapeutics (PTCT)$3.5B
Recursion Pharmaceuticals (RXRX)$2.8B
Dyne Therapeutics (DYN)$2.6B
Catalyst Pharmaceuticals (CPRX)$2.6B
AMNEAL PHARMACEUTICALS, INC (AMRX)$2.4B
NewAmsterdam Pharma (NAMS)$2.4B
Centessa Pharmaceuticals (CNTA)$2.3B
Soleno Therapeutics (SLNO)$2B
Indivior (INDV)$1.7B
Xencor (XNCR)$1.7B
BioCryst Pharmaceuticals (BCRX)$1.6B
Evotec AG (EVO)$1.5B
Ocular Therapeutix (OCUL)$1.4B
Harrow (HROW)$1.3B
Guardian Pharmacy Services (GRDN)$1.3B